How Can Advances in Technology Help Address Heterogeneity?
Advancements in omics technologies (such as genomics, proteomics, and metabolomics) and bioinformatics tools offer promising avenues for understanding and addressing heterogeneity. These technologies enable the identification of specific genetic or molecular markers associated with differential responses to toxicants. Furthermore, approaches like personalized medicine and in silico models can tailor risk assessments and interventions to individual variability, improving the accuracy and efficacy of safety evaluations.
